# Metagenomi Therapeutics, Inc.: Form 8-K, filed May 14, 2025

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: 8-K
- Filed: 2025-05-14
- Accepted by EDGAR: May 14, 2025, 07:15 ET
- Period: 2025-05-14
- Accession: 0000950170-25-070906
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000095017025070906/mgx-20250514.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000095017025070906/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000095017025070906/mgx-20250514.htm

Filed May 14, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-070906. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.